Respiratory Syncytial Virus Infection in Children with Neuromuscular Impairment

  • Simon A
13Citations
Citations of this article
66Readers
Mendeley users who have this article in their library.

Abstract

Clinically obvious reasons why children with neurological impairment (NMI) may be more severely affected in case of a viral respiratory tract infection include reduced vital capacity due to muscular weakness or spastic scoliosis, disturbed clearance of respiratory excretions (weak coughing and dysphagia), inability to comply actively with physiotherapeutic interventions, recurrent micro-aspirations (gastroesophageal reflux disease, vomiting related to coughing), a history of frequent exposure to antibiotics and health care institutions, colonization with resistant pathogens, impaired immunologic defence mechanisms due to severe malnutrition and cachexia, and early clinical deterioration in case of high fever with metabolic acidosis and hypercapnia, and maybe associated seizures or febrile convulsions.Data from the literature suggests that in all children with NMI, who have to be hospitalized with severe clinical deterioration due to an airway infection, at least one specimen of nasopharyngeal secretions should be sent as soon as possible to a virologic laboratory to detect viral pathogens. Children with severe NMI and those mechanically ventilated for other reasons being hospitalized during the RSV season must be strictly protected against nosocomial RSV infection by means of standard and droplet precautions. Finally, children with severe NMI and age below 24 months of life should receive passive immunization with palivizumab following international recommendations.

References Powered by Scopus

Risk of Primary Infection and Reinfection With Respiratory Syncytial Virus

1318Citations
N/AReaders
Get full text

Palivizumab prophylaxis reduces hospitalization due to respiratory syncytial virus in young children with hemodynamically significant congenital heart disease

679Citations
N/AReaders
Get full text

Bronchiolitis

371Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Revised recommendations concerning palivizumab prophylaxis for respiratory syncytial virus (RSV)

69Citations
N/AReaders
Get full text

Respiratory syncytial virus infection in high-risk infants - An update on palivizumab prophylaxis

34Citations
N/AReaders
Get full text

Use of palivizumab in infants and young children with severe respiratory disease: A delphi study

33Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Simon, A. (2012). Respiratory Syncytial Virus Infection in Children with Neuromuscular Impairment. The Open Microbiology Journal, 5(1), 155–158. https://doi.org/10.2174/1874285801105010155

Readers over time

‘13‘14‘15‘16‘17‘18‘19‘20‘21‘22‘23‘24‘2505101520

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 24

75%

Researcher 6

19%

Professor / Associate Prof. 2

6%

Readers' Discipline

Tooltip

Medicine and Dentistry 23

74%

Agricultural and Biological Sciences 5

16%

Nursing and Health Professions 2

6%

Chemical Engineering 1

3%

Article Metrics

Tooltip
Mentions
News Mentions: 1

Save time finding and organizing research with Mendeley

Sign up for free
0